Drugs / Compound Cyclophosphamide Tablets
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06683885 Background | Nov 2024 → May 2026 overdue | diffuse large B-cell lymphoma | Mingzhi Zhang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound Cyclophosphamide Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06683885 ↗ |
| Route | Oral | “Compound Cyclophosphamide Tablets, 50mg:50mg BID, P.O.” NCT06683885 ↗ |